I CAN Study, a phase 3 study for IgAN

This is a webinar discussing the I CAN Study, a phase 3 study for IgAN. Hosted by The IgAN Foundation and Alexion. See below for lists of questions now answered, following the Webinar



Can you also be on Filsapri?

Yes, if the patient is on stable dose for at least 3 months before signing the ICF and remain on a stable dose for the duration of the treatment period.



Is FSGS a clinically significant exclusionary disease? I have both FSGS and IgAN.

It will be at Principal Investigators (PI’s) discretion. FSGS is not exclusionary, but if the disease is clinically significant then PI might decide that this would not be a good option for the patient.



What are the eligibility requirements for enrolling in the clinical trial?

Be at least 18 years of age
Have a diagnosis of IgAN based on Kidney Biopsy
Have been treated with stable blood pressure medications for your IgAN for more than three months before screening.
Not have a history of kidney transplant or plan to undergo a transplant during the treatment period
Have protein in your urine


Are there nephrologists within Colorado who are part of this study?

Yes, in Aurora, CO



Does this study require the biopsy slides from the hospitals who performed the biopsy or can we use our reports to show the diagnosis?

A report is enough